Corgi U.S. Biotech 2x Daily ETF (XBIX) price, chart and fund profile
Price chart
Fund profile
XBIX seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the SPDR S&P Biotech ETF.
- Issuer
- Corgi Strategies, LLC
- Industry
- —
- Inception
- Jun 3, 2026
- Assets under management
- $828,922.00
- Expense ratio
- 0.45%
- Net asset value
- $41.35
- NAV as of
- Aug 27, 2026
- Leverage
- 2×
- Fund page
- corgifunds.com↗
Frequently asked questions
What is Corgi U.S. Biotech 2x Daily ETF (XBIX)?
XBIX seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the SPDR S&P Biotech ETF.
What is XBIX's expense ratio?
Corgi U.S. Biotech 2x Daily ETF charges an annual expense ratio of 0.45%. The fund is issued by Corgi Strategies, LLC.
How large is XBIX?
Corgi U.S. Biotech 2x Daily ETF manages $828,922.00 in assets and has traded since Jun 3, 2026.
How do I buy shares of Corgi U.S. Biotech 2x Daily ETF (XBIX)?
XBIX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.